Bulletin
Investor Alert

New York Markets Open in:

Amgen Inc.

NAS: AMGN

GO
/marketstate/country/us

Before the Bell

/zigman2/quotes/209157011/composite

$

210.37

Change

-0.0100 -0.0048%

Volume

Volume 43

Feb 26, 2020, 5:17 a.m.

Real time quotes

/zigman2/quotes/209157011/composite

Previous close

$ 210.38

$ 210.38

Change

-7.50 -3.44%

Day low

Day high

$209.82

$219.56

Open
Open: 218.08

52 week low

52 week high

$166.30

$244.99

Open

Market cap

$124.08B

Average volume

2.28M

P/E ratio

16.35

Rev. per Employee

$1.11M

EPS

12.87

Dividend

1.60

Div yield

3.04%

Ex dividend date

2/13/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/amgn

MarketWatch News on AMGN

  1. Teva Reports Earnings Tomorrow. Here’s What to Expect.

    7:15 a.m. Feb. 11, 2020

    - Josh Nathan-Kazis

  2. Bristol-Myers Just Reported Earnings. Its Stock Is Jumping.

    8:29 a.m. Feb. 6, 2020

    - Josh Nathan-Kazis

  3. Amgen Stock Falls on a Weaker-Than-Expected Outlook

    8:52 a.m. Jan. 31, 2020

    - Josh Nathan-Kazis

  4. Amgen stock slips as quarter beats Street view but outlook doesn't

    4:10 p.m. Jan. 30, 2020

    - Wallace Witkowski

  5. Amgen stock slips 1% as earnings beat Street, outlook doesn't

    4:03 p.m. Jan. 30, 2020

    - Wallace Witkowski

  6. Amgen Reports Earnings Tomorrow. Here’s What to Expect.

    7:00 a.m. Jan. 29, 2020

    - Josh Nathan-Kazis

  7. Tesla, Apple, Boeing, Amazon, and Other Stocks to Watch This Week

    4:35 p.m. Jan. 27, 2020

    - Nicholas Jasinski

  8. The Dow is about to face its stiffest test in years

    11:59 a.m. Jan. 26, 2020

    - Emily Bary

  9. Amgen Stock Is Poised to Gain in 2020, Analyst Says

    10:39 a.m. Jan. 23, 2020

    - Josh Nathan-Kazis

  10. Amgen stock price target raised to $238 from $194 at UBS

    10:04 a.m. Jan. 22, 2020

    - Tomi Kilgore

  11. Amgen upgraded to overweight from in line at Evercore ISI

    9:13 a.m. Jan. 21, 2020

    - Tomi Kilgore

  12. Big Merger Deals Are Missing at Health Conference. Here’s Why.

    11:13 a.m. Jan. 14, 2020

    - Josh Nathan-Kazis

  13. Amgen stock price target raised to $275 from $240 at BMO Capital

    11:45 a.m. Jan. 9, 2020

    - Tomi Kilgore

  14. For Dividend Growth, Consider Health-Care and Tech Stocks

    6:45 a.m. Jan. 9, 2020

    - Lawrence C. Strauss

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/amgn

Other News on AMGN

  1. Lundbeck's Pullback Makes It Worth Considering Again

    6:50 p.m. Feb. 25, 2020

    - Seeking Alpha

  2. Berkshire Hathaway: No Urgency in the Urgent Zone

    1:26 p.m. Feb. 25, 2020

    - GuruFocus.com

  3. Sanders' big Nevada primary win shakes health-related stocks

    10:10 a.m. Feb. 24, 2020

    - Seeking Alpha

  4. Amgen (AMGN) Receives a Buy from Credit Suisse

    8:22 a.m. Feb. 24, 2020

    - SmarterAnalyst

  5. FDA Clears New Type of Cholesterol Drug

    6:52 p.m. Feb. 21, 2020

    - Jared S. Hopkins

  6. Dems attack Trump over stalled efforts to lower drug prices

    9:32 a.m. Feb. 21, 2020

    - Seeking Alpha

  7. Stalled Initiatives to Cut Drug Prices Frustrate Trump

    7:00 a.m. Feb. 21, 2020

    - Stephanie Armour

  8. 15 Top ESG Stocks That Look Undervalued for 2020

    7:04 a.m. Feb. 20, 2020

    - 247WallSt.com

  9. How the Drug Lobby Lost Its Mojo in Washington

    12:15 p.m. Feb. 19, 2020

    - Brody Mullins

  10. Bull of the Day: Guardant Health (GH)

    5:44 a.m. Feb. 19, 2020

    - Zacks.com

  11. RetirementRx 2019: A Look In The Rearview

    12:00 a.m. Feb. 19, 2020

    - Seeking Alpha

  12. Healthcare And Biotechnology Dashboard - Update

    5:34 p.m. Feb. 18, 2020

    - Seeking Alpha

  13. Veeva: A Compelling Buy In The Niche Healthcare Cloud Sector

    6:55 p.m. Feb. 16, 2020

    - Seeking Alpha

  14. Leaner, More Agile Teva Has Brighter Days Ahead

    1:42 p.m. Feb. 13, 2020

    - GuruFocus.com

  15. Loading more headlines...
/news/pressrelease/company/us/amgn

Press Releases on AMGN

  1. Rare Hematology Market Economic Forecasting By Key Players 2029 | Biogen and Novo Nordisk A/S

    2:24 a.m. Today

    - marketresearch.biz

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.